MAPK3 and non-small cell lung carcinoma: Accordingly, we also discovered that CYP3A43 overexpression inhibits the activation of ERK1/2, which suggested that CYP3A43 overexpression suppresses NSCLC cell growth by inhibiting the ERK1/2 activation.